In organosulfur chemistry, a mesylate is any salt or ester of methanesulfonic acid (). In salts, the mesylate is present as the anion. When modifying the international nonproprietary name of a medication containing the group or anion, the spelling used is sometimes mesilate (as in imatinib mesilate, the mesylate salt of imatinib).
Mesylate esters are a group of that share a common functional group with the general structure , abbreviated , where R is an organic substituent. Mesylate is considered a leaving group in nucleophilic substitution reactions.
Preparation
Mesylate esters are generally prepared by treating an alcohol and methanesulfonyl chloride in the presence of a base, such as
triethylamine.
[ (a procedure illustrating the use of mesylates).]
Mesyl
Related to mesylate is the
mesyl (Ms) or methanesulfonyl () functional group. The shortened term itself was coined by Helferich et al. in 1938 similarly to
Tosyl group adopted earlier.
Methanesulfonyl chloride is often referred to as mesyl chloride.
Whereas mesylates are often hydrolysis labile, mesyl groups, when attached to nitrogen, are resistant to hydrolysis. This functional group appears in a variety of medications, particularly cardiac (antiarrhythmic) drugs, as a sulfonamide moiety. Examples include sotalol, ibutilide, sematilide, dronedarone, dofetilide, E-4031, and bitopertin.
Pharmaceutical preparations
Mesylate salts are often used in preparing the dosage forms of basic drugs. Mesylate salts often yield a higher solubility, and may also excel in other pharmaceutically-relevant factors such as hygroscopicity, clean polymorphic profile, particle size, and flow properties.
Natural occurrence
Ice core samples from a single spot in Antarctica were found to have tiny inclusions of magnesium methanesulfonate dodecahydrate. This natural phase is recognized as the mineral
ernstburkeite. It is extremely rare.
See also